AHA 2018 | Freedom Long-Term Follow-up: Still in Favor of CABG

Nearly 8 years later, CABG maintains its benefit over PCI-DES in terms of mortality in diabetic patients with multivessel disease, according to the Freedom trial, presented by Dr. Fuster at AHA and simultaneously published in JACC.

AHA 2018 | Seguimiento a largo plazo del Freedom: se mantiene el beneficio a favor de la cirugíaCABG is superior to PCI-DES, with 36% higher mortality in these last years.

 

Considering the nature of atherosclerosis, where results are seen at long term, the Freedom outcomes at mean 3.8 and 6 years seemed short to compare both strategies, shorter even with mortality as primary end point.

 

In the first report at 3.8-year follow-up, all-cause mortality was 16.3% and 10.9% for PCI-DES and CABG, respectively (p=0.05). At 7.5 years, mortality was 23.7% and 18.7%, respectively.


Read also: Clinical Improvement Without Ventricular Function Improvement After CTO.


The difference in favor of CABG was observed in practically all subgroups, and the younger patients saw greater benefits.

 

For 63.3 year-old patients or younger, mortality was 10.2% with CABG vs 20.7% at the end of follow-up (p=0.01 age interaction).

 

Both the American and the European guidelines have a class I recommendation with evidence level B for all diabetics with multivessel disease, regardless syntax score.

 

Original title: Long-term survival following multivessel revascularization in patients with diabetes (FREEDOM Follow-On study).

Reference: Farkouh ME et al. J Am Coll Cardiol. 2018;Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

FLAVOUR Trial Substudy: FFR or IVUS in the Assessment of Diabetic Patients

Patients with diabetes often present with more complex coronary artery disease compared to non-diabetic patients, with a higher prevalence of diffuse or multivessel disease....

Mechanical Circulatory Support in Complex Anatomies and Severe Deterioration of Left Ventricular Function

Severe coronary artery disease (CAD) frequently causes left ventricular function deterioration, and is often treated with myocardial revascularization surgery (CABG), especially when ejection fraction...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...